Insider · CIK 0001256088

GEMAYEL GEORGES

Reports to the SEC for 9 companies · WATERTOWN, MA

sec.gov

Transactions

Companies

Filings

CIK

0001256088

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-18	IRONDisc Medicine, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,212 sh	—	—	6,212
2026-03-06	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+7,905 sh	$25.30	+$200K	36,064
2026-03-06	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,905 sh	—	—	0
2026-03-06	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Director	SSale	−8,787 sh	$53.00	−$466K	27,277
2026-03-05	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Director	SSale	−10K sh	$53.71	−$537K	28,159
2026-02-24	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Director	AAward	+4,475 sh	—	—	38,159
2026-02-24	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−4,475 sh	—	—	0
2026-02-23	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$12.98	+$195K	33,684
2026-02-23	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2026-02-18	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitA Award	Director	AAward	+2,989 sh	—	—	2,989
2026-02-18	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+4,977 sh	—	—	4,977
2025-09-16	IRONDisc Medicine, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,000 sh	—	—	1,000
2025-06-11	IRONDisc Medicine, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2025-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−5,369 sh	—	—	0
2025-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Director	AAward	+5,369 sh	—	—	18,684
2025-02-19	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+7,296 sh	—	—	7,296
2025-02-19	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitA Award	Director	AAward	+4,475 sh	—	—	4,475
2024-11-08	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Director	SSale	−10.8K sh	$36.30	−$392K	13,315
2024-11-08	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+10.8K sh	$11.46	+$124K	24,102
2024-11-08	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10.8K sh	—	—	0
2024-11-07	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+14.2K sh	$11.46	+$163K	27,528
2024-11-07	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Director	SSale	−14.2K sh	$36.62	−$520K	13,315
2024-11-07	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−14.2K sh	—	—	10,787
2024-09-13	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Director	SSale	−10K sh	$31.33	−$313K	13,315
2024-09-13	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$11.46	+$115K	23,315
2024-09-13	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	Director	SSale	−3,886 sh	$31.33	−$122K	13,315
2024-09-13	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	25,000
2024-06-12	IRONDisc Medicine, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2024-02-23	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Director	AAward	+3,886 sh	—	—	17,201
2024-02-23	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−3,886 sh	—	—	0
2024-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+8,252 sh	—	—	8,252
2024-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+5,369 sh	—	—	5,369
2023-06-09	IRONDisc Medicine, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,136 sh	—	—	7,136
2023-02-23	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+3,886 sh	—	—	3,886
2023-02-23	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+6,293 sh	—	—	6,293
2023-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−3,882 sh	—	—	0
2023-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Director	AAward	+3,882 sh	—	—	13,315
2022-12-29	IRONDisc Medicine, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2022-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+6,847 sh	—	—	6,847
2022-02-22	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+3,882 sh	—	—	3,882
2022-02-19	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−4,222 sh	—	—	0
2022-02-19	SUPNSUPERNUS PHARMACEUTICALS, INC.A Award	Director	AAward	+4,222 sh	—	—	9,433
2022-01-03	IRONDisc Medicine, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+793K sh	—	—	793,274
2021-11-15	IRONDisc Medicine, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.2K sh	—	—	17,245
2021-11-15	IRONDisc Medicine, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+23.5K sh	—	—	23,514
2021-04-29	IRONDisc Medicine, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+45.5K sh	—	—	45,466
2021-02-19	SUPNSUPERNUS PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+4,222 sh	—	—	4,222
2021-02-19	SUPNSUPERNUS PHARMACEUTICALS, INC. · Director Stock Option (Right to Buy)A Award	Director	AAward	+7,365 sh	—	—	7,365
2020-10-01	MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2020-10-01	MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0

Recent filings

Accepted (ET)
Jun 234
GEMAYEL GEORGES0001193125-26-279712
SEC(opens sec.gov)
Mar 94
GEMAYEL GEORGES0001256088-26-000006
SEC(opens sec.gov)
Feb 254
GEMAYEL GEORGES0001256088-26-000004
SEC(opens sec.gov)
Feb 204
GEMAYEL GEORGES0001256088-26-000002
SEC(opens sec.gov)
Sep 184
GEMAYEL GEORGES0001193125-25-207557
SEC(opens sec.gov)
Jun 134
GEMAYEL GEORGES0000950170-25-086384
SEC(opens sec.gov)
Feb 244
GEMAYEL GEORGES0001628280-25-007463
SEC(opens sec.gov)
Feb 214
GEMAYEL GEORGES0001628280-25-007186
SEC(opens sec.gov)
Nov 124
GEMAYEL GEORGES0001628280-24-047145
SEC(opens sec.gov)

Companies

Address

C/O DISC MEDICINE, INC. 321 ARSENAL STREET, SUITE 101

WATERTOWN, MA, 02472